Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Asset Utilization Ratio came in at 0.04 in Q1 2026, up 64.63% year-on-year from 0.02 in Q1 2025, and up 2.86% quarter-over-quarter from 0.03 in Q4 2025.
Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Asset Utilization Ratio across 3 years of filings, most recently posting 0.04 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.04, up 64.63% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.04 (up 64.63% YoY), and the FY2025 annual result was 0.04, up 264.53% from the prior year.
- Asset Utilization Ratio came in at 0.04 for Q1 2026 at Camp4 Therapeutics, up from 0.03 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.06 in Q3 2025 to a low of 0.01 in Q4 2024.
- The 3-year median for Asset Utilization Ratio is 0.03 (2025), against an average of 0.04.
- Across the five-year window, Asset Utilization Ratio surged 161.87% in 2025 and soared 64.63% in 2026, its largest moves.
- Camp4 Therapeutics' Asset Utilization Ratio stood at 0.01 in 2024, then soared by 161.87% to 0.03 in 2025, then gained by 2.86% to 0.04 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.04 (Q1 2026), 0.03 (Q4 2025), and 0.06 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 0.55 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.01 |